Adagene Statistics
NASDAQ: ADAGHealthcareBiotechnologyUSD
2.81-0.12 (-4.10%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Adagene by the numbers
Adagene has a market capitalization of $188.7 million based on 67.14M shares outstanding. With trailing EPS of $-0.37, Adagene is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.7% below its 50-day average and 16.3% below its 200-day average.
Average daily trading volume is 246.37K shares, or about $692,286 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ADAG valuation vs. peer median
| Metric | ADAG | Peer median | Difference |
|---|---|---|---|
| Market cap | $188.67M | $185.39M | +2% |
| Avg. volume | 246.37K | 474.30K | -48% |
Peer median across 8 companies: NGEN, CMPX, ANTX, WHWK, ORMP, ELDN, ACOG, CNTN.
Valuation
- Market cap
- $188.67M
- EPS (TTM)
- $-0.37
- Shares outstanding
- 67.14M
Price and trading
- Previous close
- 2.93
- Open
- 2.90
- Day range
- 2.79 – 3.10
- 52-week range
- 1.30 – 4.85
- 52-week change
- +41.21%
- Beta
- —
- Volume
- 173.06K
- Average volume
- 246.37K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Jul 23, 2025
Additional statistics
- Market Cap
- 188.67M
- Forward Pe
- -5.02
- Eps
- -0.37
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.85
- Week52 Low
- 1.30
- Avg Volume
- 246.37K
- Shares Outstanding
- 67.14M
- Ma50
- 3.54
- Ma200
- 3.36
- Earnings Date
- Jul 23, 2025
- Pct From52w High
- -42.06%
- Pct From52w Low
- 116.15%